News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
874,100 Results
Type
Article (88226)
Company Profile (823)
Press Release (785030)
Multimedia
Podcasts (209)
Webinars (32)
Section
Business (233363)
Career Advice (4152)
Deals (39899)
Drug Delivery (160)
Drug Development (91491)
Employer Resources (205)
FDA (18450)
Job Trends (17442)
News (398171)
Policy (39999)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3025)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (166)
Alliances (56982)
ALS (195)
Alzheimer's disease (1835)
Antibody-drug conjugate (ADC) (385)
Approvals (18651)
Artificial intelligence (693)
Autoimmune disease (212)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (213)
Biotechnology (490)
Bladder cancer (178)
Brain cancer (70)
Breast cancer (704)
Cancer (5411)
Cardiovascular disease (481)
Career advice (3580)
Career pathing (44)
CAR-T (320)
CDC (68)
Celiac Disease (2)
Cell therapy (882)
Cervical cancer (41)
Clinical research (77538)
Collaboration (1988)
Company closure (6)
Compensation (1261)
Complete response letters (86)
COVID-19 (3007)
CRISPR (110)
C-suite (989)
Cystic fibrosis (157)
Data (6811)
Decentralized trials (2)
Denatured (77)
Depression (170)
Diabetes (560)
Diagnostics (7342)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (337)
Drug pricing (232)
Drug shortages (36)
Duchenne muscular dystrophy (271)
Earnings (100873)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (136017)
Executive appointments (1081)
FDA (21862)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1667)
Gene editing (235)
Generative AI (72)
Gene therapy (729)
GLP-1 (1177)
Government (5487)
Grass and pollen (8)
Guidances (390)
Healthcare (20988)
HIV (77)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (312)
Immuno-oncology (81)
Indications (140)
Infectious disease (3332)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (270)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (100)
Layoffs (664)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (23)
Lung cancer (721)
Lymphoma (400)
Machine learning (49)
Management (66)
Manufacturing (947)
MASH (187)
Medical device (15105)
Medtech (15175)
Mergers & acquisitions (23061)
Metabolic disorders (1508)
mRNA (207)
Multiple sclerosis (181)
NASH (23)
Neurodegenerative disease (395)
Neuropsychiatric disorders (110)
Neuroscience (3284)
Neurotech (1)
NextGen: Class of 2026 (7711)
Non-profit (5127)
Now hiring (70)
Obesity (738)
Opinion (350)
Ovarian cancer (178)
Pain (238)
Pancreatic cancer (256)
Parkinson's disease (327)
Partnered (39)
Patents (555)
Patient recruitment (568)
Peanut (65)
People (67219)
Pharmaceutical (144)
Pharmacy benefit managers (34)
Phase 1 (23954)
Phase 2 (33648)
Phase 3 (25350)
Pipeline (6377)
Policy (364)
Postmarket research (3554)
Preclinical (10740)
Press Release (72)
Prostate cancer (275)
Psychedelics (61)
Radiopharmaceuticals (319)
Rare diseases (1040)
Real estate (7445)
Recruiting (81)
Regulatory (29425)
Reports (69)
Research institute (2748)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (91)
Schizophrenia (166)
Series A (281)
Series B (207)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (180)
Sponsored (49)
Startups (4342)
State (2)
Stomach cancer (21)
Supply chain (123)
Tariffs (101)
The Weekly (129)
Vaccines (1198)
Venture capital (104)
Weight loss (505)
Women's health (108)
Worklife (23)
Date
Today (168)
Last 7 days (750)
Last 30 days (3327)
Last 365 days (32847)
2026 (6416)
2025 (33228)
2024 (38138)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (357)
Arkansas (15)
Asia (51727)
Australia (9091)
California (12343)
Canada (3511)
China (1250)
Colorado (522)
Connecticut (540)
Delaware (368)
Europe (119071)
Florida (1837)
Georgia (399)
Hawaii (4)
Idaho (68)
Illinois (1032)
India (82)
Indiana (580)
Iowa (24)
Japan (473)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1530)
Massachusetts (9077)
Michigan (381)
Minnesota (697)
Mississippi (7)
Missouri (149)
Montana (37)
Nebraska (30)
Nevada (137)
New Hampshire (88)
New Jersey (3321)
New Mexico (33)
New York (3255)
North Carolina (1699)
North Dakota (10)
Northern California (5976)
Ohio (380)
Oklahoma (23)
Oregon (55)
Pennsylvania (2461)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (72)
South Dakota (1)
Southern California (4791)
Tennessee (196)
Texas (1948)
United States (44438)
Utah (372)
Vermont (1)
Virginia (312)
Washington D.C. (88)
Washington State (1021)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 874,100 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vantage Nutrition Appoints Croft Hollingsworth as Site Director to Support Growth in North America
March 10, 2026
·
1 min read
Press Releases
Theralase(R) Closes $1.1 M Non-Brokered Private Placement
March 10, 2026
·
1 min read
Press Releases
Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT
March 10, 2026
·
1 min read
Press Releases
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements
March 10, 2026
·
2 min read
Press Releases
Fziomed Announces Clinical Results from Level I Study Evaluating Oxiplex Absorbable Gel for Spine Surgery
March 10, 2026
·
3 min read
Press Releases
MiniMed expands sensor portfolio in Europe with CE Mark for MiniMed™ 780G system with the Instinct sensor, made by Abbott
March 10, 2026
·
3 min read
Press Releases
Citius Oncology Announces Positive Topline Results from Investigator‑Initiated Phase 1 Study of LYMPHIR™ in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers
March 10, 2026
·
15 min read
Press Releases
Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
March 10, 2026
·
5 min read
Rare diseases
Senator Ron Johnson Launches Investigation Into FDA Rare Disease Rejections
The senator, who has long advocated for expanding access to experimental therapies, reportedly called the FDA’s request for a sham surgery–controlled Phase 3 trial for uniQure’s Huntington’s disease gene therapy “bureaucratic idiocy.”
March 10, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Longeveron Announces Private Placement of up to $30 Million
March 10, 2026
·
8 min read
1 of 87,410
Next
